San Diego California | U.S.A.
| Investor Type | Firm |
| Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer |
| Stages | Seed, Series A, Series B, Pre-seed |
| Investing | United States |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
About The Fund
Boxer Capital Management is an investment firm with a focus on biotechnology companies, aiming to make profound contributions to medicine. They are dedicated to full life cycle investing, engaging with companies across both private and public markets to drive innovation in specialized and precision medicine. Their investment philosophy is rooted in a disciplined analysis to uncover opportunities that have the potential to deliver transformative medical advancements, specifically in the area of precision medicine. With an investment approach that responds dynamically to the shifting biotechnology ecosystem, Boxer Capital adapts their investment research and strategies to remain competitive and innovative. Their team is composed of scientists with notable experience in leading drug research and discovery, coupled with almost two decades of investment expertise, providing a solid foundation for their investment decisions. Their investment process combines bottom-up idea generation with top-down oversight from their founder, ensuring thorough and rigorous evaluation of potential investments. Boxer Capital Management boasts a rigorous multi-disciplinary analysis framework, evaluating investments from scientific, clinical, commercial, and regulatory perspectives to ensure a clear investment rationale and the selection of the right management teams. Their focus is not limited to financial support; they also serve as trusted partners to their portfolio companies, contributing to strategic decisions and growth. Emphasizing the importance of fundamental and scientific research, Boxer Capital seeks to unlock better patient care and advance medicine for all. They prioritize early-stage investments around innovative drug targets, leveraging the predictive value of their team’s fundamental due diligence. Their investment range typically extends from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot around $1,500,000. They specialize in stages covering Seed, Series A, Series B, and Pre-seed funding rounds.
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
